Balamurugan Krishnaswamy, Vaziri Nosratola D, Said Hamid M
VA Medical Center-151, Long Beach, CA 90822, USA.
Am J Physiol Renal Physiol. 2005 Apr;288(4):F823-31. doi: 10.1152/ajprenal.00375.2004. Epub 2004 Nov 23.
Cellular and molecular regulation of renal biotin uptake in humans is not well defined. The contribution of the human Na(+)-dependent multivitamin transporter (hSMVT) to carrier-mediated biotin uptake by human proximal tubular epithelial cells is not clear. The aim of this study was to address these issues, with the human-derived proximal tubular epithelial HK-2 cells used as a model. First, we characterized the mechanism of biotin uptake by these cells and obtained evidence for involvement of an Na(+)-, temperature-, and energy-dependent carrier-mediated uptake system. This system was inhibited by the biotin structural analog desthiobiotin, pantothenic acid, and lipoate. These findings suggest involvement of the hSMVT system in the uptake process. This was confirmed by demonstrating that the hSMVT system is expressed in HK-2 cells at the protein and mRNA levels and by selective silencing of the hSMVT gene with the use of gene-specific small interfering RNAs, which led to specific and significant inhibition of carrier-mediated biotin uptake. Of the two recently cloned promoters of the hSMVT gene, promoter 1 was more active than promoter 2 in these cells. Pretreatment of HK-2 cells with modulators of PKC- and Ca(2+)/calmodulin-mediated pathways (but not those that modulate PKA-, protein tyrosine kinase-, or nitric oxide-mediated pathways) led to significant alterations in biotin uptake. Maintaining the HK-2 cells in a biotin-deficient growth medium led to a marked upregulation in biotin transport, which was associated with an increase in hSMVT protein and RNA levels and an increase in activity of the hSMVT promoters. These results demonstrate that biotin uptake by human renal epithelial cells occurs via the hSMVT system and that the process is regulated by intracellular PKC- and Ca(2+)/calmodulin-mediated pathways. The uptake process appears to be adaptively regulated by extracellular biotin level, which involves transcriptional regulatory mechanism(s).
人体肾脏生物素摄取的细胞和分子调节尚未明确界定。人类钠离子依赖性多种维生素转运体(hSMVT)对人近端肾小管上皮细胞载体介导的生物素摄取的贡献尚不清楚。本研究的目的是利用人源近端肾小管上皮HK-2细胞作为模型来解决这些问题。首先,我们对这些细胞摄取生物素的机制进行了表征,并获得了钠离子、温度和能量依赖性载体介导摄取系统参与其中的证据。该系统受到生物素结构类似物脱硫生物素、泛酸和硫辛酸的抑制。这些发现表明hSMVT系统参与了摄取过程。通过证明hSMVT系统在HK-2细胞中蛋白和mRNA水平均有表达,以及使用基因特异性小干扰RNA对hSMVT基因进行选择性沉默,导致载体介导的生物素摄取受到特异性和显著抑制,从而证实了这一点。在hSMVT基因最近克隆的两个启动子中,启动子1在这些细胞中的活性比启动子2更高。用蛋白激酶C和钙调蛋白介导途径的调节剂(而非调节蛋白激酶A、蛋白酪氨酸激酶或一氧化氮介导途径的调节剂)预处理HK-2细胞,会导致生物素摄取发生显著变化。将HK-2细胞维持在生物素缺乏的生长培养基中会导致生物素转运显著上调,这与hSMVT蛋白和RNA水平增加以及hSMVT启动子活性增加有关。这些结果表明,人肾上皮细胞摄取生物素是通过hSMVT系统进行的,且该过程受细胞内蛋白激酶C和钙调蛋白介导途径的调节。摄取过程似乎受到细胞外生物素水平的适应性调节,这涉及转录调节机制。